The dual inhibition of the PI3K and MAPK pathways might overcome the resistance to PI3K/mTOR inhibition alone in certain endometrial tumors with K-Ras alterations through its enhanced cytostatic effect (at least in part). The gene discussed is MTOR; the disease is endometrium neoplasm.